 |
| Hepatitis C Virus Image via Wikipedia |
Written by Patrick Crutcher Tuesday, 11 January 2011
Zacks.com Profile: PPHM
Peregrine Pharmaceutical Pipeline
Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) announced that it has initiated several trials in oncology and viral infections. They seem poised to garner attention from the Street over the coming months.
Continued
